Korro Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing RNA-editing genetic medicines for rare and more common diseases. The company’s programs are designed to make precise changes at the RNA level, aiming to address disease-causing biology without permanently altering DNA. Its current pipeline includes lead candidate KRRO-121, a GalNAc-conjugated RNA editing oligonucleotide under development for hyperammonemia in patients with urea cycle disorders and hepatic encephalopathy, along with additional research programs in liver and other therapeutic areas. Korro Bio’s platform is built around programmable RNA editing and oligonucleotide-based delivery, positioning the company within the growing field of next-generation genetic medicines. Based in Cambridge, Massachusetts, Korro Bio focuses on discovery and development activities across its research and clinical-stage portfolio.
Website30 Hudson Yards
New York, NY, 10001
United States
Six affiliates invest in KKR-backed company as conglomerate expands beyond chips
Investors talking about KKR also mention
| # | Name | Attention |
|---|---|---|
| 1 | Blackstone Inc.BX | 0.01%+0.01 |
| 2 | Apollo Global Management LLCAPO | 0%new |
| 3 | TPG Inc. Class A Common StockTPG | 0%0 |
| 4 | Hamilton Lane Inc. Class AHLNE | 0%0 |
| 5 | FS KKR Capital Corp.FSK | 0%0 |
| 6 | Vornado Realty TrustVNO | 0%-0.01 |
| 7 | Ares Management Corp. Class A Common StockARES | 0.01%new |
| 8 | DigitalBridge Group Inc. Class A Common StockDBRG | 0%0 |
| 9 | The Carlyle Group Inc.CG | 0%new |
| 10 | Blue Owl Capital Inc.OWL | 0%0 |
What share of all stock conversation is about KKR?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% new | 0% 0 | 0% 0 | 0.02% +0.02 |
Of the messages about KKR that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | 66.67% +66.67 | 77.95% -16.67 | 42.24% -21.89 | ||
| Bearish | — | 33.33% -66.67 | 22.05% +16.67 | 57.76% +21.89 |
Of the messages about KKR that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | 100% | 77.08% | 23.48% | 7.23% | ||
| Technical Analysis | 0% | 0% | 1.46% | 0.46% | ||
| Macro | 0% | 22.92% | 38.2% | 84.24% | ||
| Analysts | 0% | 0% | 36.85% | 6.85% | ||
| Earnings | 0% | 0% | 0% | 0.87% | ||
| Controversies | 0% | 0% | 0% | 0.36% |
Of the messages about KKR, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 100% | 75.47% | 38.18% | 4.93% | ||
| Newcomers | 0% | 24.53% | 61.82% | 95.07% |